Financials
Financial year 2025
Klerck Pharma Services & Consultancy from Huldenberg, company number BE0744377307, closed financial year 2025 with a result of € 9,776 after tax. For that financial year Klerck Pharma Services & Consultancy recorded a gross margin of € 27,080 and equity of € 14,361. Compared with financial year 2024, the result moved from € 18,661 to € 9,776. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.
€ 14,361
▲ 213% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 9,776
▼ 48% vs 2024
Profit after tax over the fiscal year.
€ 47,895
▼ 14% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 13,361.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 12,399
▼ 31% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 6,289
▼ 35% vs 2024
€ 3,550 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 3,732
▲ € 3,308 vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -3,729 | € 26,642 | € 32,333 | € 27,080 | ▼ 16% |
| Profit after taxes | € -6,365 | € 14,496 | € 18,661 | € 9,776 | ▼ 48% |
| Equity | € 42,088 | € 4,584 | € 4,585 | € 14,361 | ▲ 213% |
| Total debts | € 24,778 | € 71,944 | € 72,653 | € 58,101 | ▼ 20% |
| Cash | € 36,231 | € 44,326 | € 55,956 | € 47,895 | ▼ 14% |
| Retained profit | € 41,088 | € 3,584 | € 3,585 | € 13,361 | ▲ 273% |
| Dividend | € 0 | € 52,000 | € 18,660 | € 0 | ▼ 100% |
| Bank debt | € 16,274 | € 13,053 | € 9,725 | € 6,289 | ▼ 35% |
| Balance sheet total | € 66,866 | € 76,528 | € 77,238 | € 72,462 | ▼ 6% |
Key figures of Klerck Pharma Services & Consultancy, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Klerck Pharma Services & Consultancy?
What happened at Klerck Pharma Services & Consultancy in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 9,776 (▼ 48% vs 2024). Source: NBB ↗
- New establishment in Huldenberg. KBO
- Charlene Klerck became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 6,365 loss in 2022 to € 9,776 profit in 2025.
Paid € 14,436 in corporate taxes since 2022.
Best year ever: 2024, with € 18,661 profit.
Paid out € 70,660 in dividends to the owners in total.
Management
Behind Klerck Pharma Services & Consultancy is Charlene Klerck .
Directors
According to the 2025 annual accounts
Charlene Klerck
Director
since 2020
Establishments
Establishment units
Physical locations of this company
Dennenlaan 3
3040 Huldenberg
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0744.377.307
- VAT number
- BE 0744.377.307
- Registered office
- Dennenlaan 3, 3040 Huldenberg
- Names & denominations
- Klerck Pharma Services & Consultancy
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 February 2020
- Peppol
- Active · Active since 24 Dec 2025
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten